full
without
#666666
https://www.aurorabiomed.com/wp-content/themes/aurora-clean/
https://www.aurorabiomed.com/
#0066FF
style2

Precision Medicine & Ion Channel Retreat 2019

17th Annual Ion Channel Retreat

Sheraton Vancouver Wall Centre

Vancouver, British Columbia, Canada

July 24th– 26th, 2019

About

Over the last 16 years, the Precision Medicine and Ion Channel Retreat (PMICR) has evolved into one of the premier conferences for drug discovery, genomics and ion channel research. The 17th annual PMICR strives to continue this proud tradition by providing a platform to explore cutting edge technology and innovative research from around the world. This diverse, thought-provoking event allows academic and industry researchers to share knowledge, exchange ideas and establish fruitful partnerships. The Retreat is designed to maximize networking opportunities, with social events providing an intimate & relaxed atmosphere.

Topics

Precision Medicine Sessions

  1. Key Methodologies in Precision Medicine for Drug Discovery
  2. Next-Generation Sequencing – Applications and Advancement of Genomic Medicine
  3. Cancer Diagnosis & Treatment
  4. Latest Applications of Liquid Biopsy Research
  5. Stem Cells in Drug Development
  6. Peptide Research & Drug Discovery
  7. CRO Involvement in Drug Discovery

Ion Channel Sessions

  1. Key Methodologies in Ion Channel Research for Drug Discovery
  2. Cardiac Safety, CiPA and its impact on Drug Discovery
  3. Role of Ion Channels in Cancer Treatment
  4. Ion Channels as Pain Targets
  5. Ion Channels as Disease Targets: Alzheimer and Neurodegenerative disease, Cystic Fibrosis, Epilepsy
  6. Emerging Areas of Ion Transporter Research
  7. Ion Channels & Immunity

Conference Venue and Social Event Information

Sheraton Vancouver Wall Centre- Pavilion Ballroom (3rd floor)
1088 Burrard Street, Vancouver
British Columbia, Canada, V6Z 2R9
Tel: +1 (604) 331-1000
https://www.marriott.com/hotels/travel/yvrws-sheraton-vancouver-wall-centre/

 

Spirit Cruises- Boat Cruise (25th July- 6pm to 9pm)
450 Denman St, Vancouver,
British Columbia, Canada, V6G 3H1
Tel: +1(604) 687-5533

Cruise Vessel: Star of Vancouver
Boarding: 5:30pm

Organization Committee

  • Bernard Fermini, Ph.D.- Chief Research and Development Officer at Novoheart
  • Chris Mathes, Ph.D.- Chief Commercial Officer at AnaBios Corporation
  • Clint Young, Ph.D.- Associate Director & Manager, Electrophysiology, Drug Discovery – Novel Human Genetic Targets at GSK
  • Marc Pourrier, Ph.D.- Vice President, Operations at IonsGate Preclinical Services Inc.

 

Scientific Advisory Board

  • Alfred L. George, M.D., Ph.D.- Chair, Department of Pharmacology and Magerstadt Professor of Pharmacology at Northwestern University Medicine
  • David Fedida, Ph.D.- Professor in Anesthesiology, Pharmacology and Therapeutics at University of British Columbia
  • Stephen Waxman, M.D., Ph.D.- Bridget M. Flaherty Professor of Neurology and of Neuroscience at Yale University
  • Terry Snutch, Ph.D.- Professor and the Canada Research Chair in Biotechnology and Genomics- Neurobiology at University of British Columbia
  • Xiaoliang Wang, M.D., Ph.D.- Professor at Chinese Academy of Medical Sciences
  • Yan Xu, Ph.D.- Peter Winter Professor of Anesthesiology & Perioperative Medicine at University of Pittsburgh
  • Zhiyuan Li, Ph.D.- Principal Investigator at Guangzhou Institutes of Biomedicine and Health

 

Confirmed Speakers

  • Aaron McMurtray, M.D., Ph.D.- Associate Clinical Professor of Neurology, David Geffen School of Medicine at University of California; Los Angeles
  • Ali Yehia, Ph.D.- Vice President IonFlux Product and Director of BioFlux Business Marketing at Fluxion Biosciences
  • Amanda Duran, Ph.D.- Protein Engineering Scientist at Cyrus Biotechnology
  • Bimal N. Desai, Ph.D.- Associate Professor of Pharmacology at Harvard University
  • Ceresa Sala, Ph.D.- Postdoctoral Fellow in the Department of Experimental and Clinical Medicine at University of Florence
  • Chris Mathes, Ph.D.- Chief Commercial Officer at AnaBios Corporation
  • Christopher Maxwell, Ph.D. – Associate Professor in the Faculty of Medicine, Department of Pediatrics at the University of British Columbia
  • Christine Beeton, Ph.D.- Graduate Program Director of Biomedical Sciences and Associate Professor in the Department of Molecular Physiology and Biophysics at Baylor College of Medicine
  • Daniel Sauter, Ph.D.- Laboratory Manager & Application Scientist at Sophion Bioscience
  • David Hackos, Ph.D.- Senior Scientist at Genentech, Inc.
  • David Smith, Ph.D.- Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic
  • Dong Liang, Ph.D.- Chief Executive Officer & President at Aurora Biomed Inc.
  • Elena Dragicevic, Ph.D. – Alliance Manager at Nanion Technologies GmbH
  • Fernanda Laezza, M.D., Ph.D.- Graduate Program Director and Associate Professor in the Department of Pharmacology and Toxicology at the University of Texas Medical Branch
  • Filip Van Petegem, Ph.D.- Professor in the Department of Biochemistry and Molecular Biology at University of British Columbia
  • George Okeyo, Ph.D.- Portfolio Manager at Nanion Technologies
  • Georg Terstappen, Ph.D.- Chief Scientific Officer at OxStem
  • Gregor Reid, Ph.D.- Associate Professor in the Faculty of Medicine
  • Heinrich Brinkmeier, Ph.D.- Professor of Pathophysiology and Molecular Medicine at the University of Medicine Greifswald
  • Irina Vetter, Ph.D.- Associate Professor at the University of Queensland
  • Isabelle Deschenes, Ph.D.- Professor of Medicine, Physiology & Biophysics and Biomedical Engineering at Case Western Reserve University
  • Jason Underwood, Ph.D.- Principal Scientist at Pacific Biosciences
  • Jeffrey Herz, Ph.D.- CEO at Algomedix Inc.
  • Jie Zheng, Ph.D.- Professor at the University of California; Davis School of Medicine
  • Jim Ellis, Ph.D.- Chief Scientific Officer at Nocion Therapeutics
  • Jonathan Davila, Ph.D.- Chief Executive Officer and Co-Founder at NeuCyte
  • JP Johnson, Ph.D.- Vice President, Biology at Xenon Pharmaceuticals Inc.
  • Khaled Barakat, Ph.D.- Assistant Professor in the Faculty of Pharmacy and Pharmaceutical Sciences at University of Alberta
  • Laura Hilton, Ph.D.- Postdoctoral Fellow at Simon Fraser University
  • Marc Pourrier, Ph.D.- Vice President, Operations at IonsGate
  • Marc Rogers, Ph.D.- Chief Scientific Officer at Metrion Biosciences
  • Marzia Martina, Ph.D.- Team Leader, Electrophysiology in Human Health Therapeutics at National Research Council of Canada
  • Merritt Maduke, Ph.D.- Associate Professor of Molecular and Cellular Physiology at Stanford University
  • Michelina Iacovino, Ph.D.- Assistant Professor in the Department of Pediatrics, David Geffen School of Medicine at University of California Los Angeles
  • Mohamed Chahine, Ph.D.- Professor in the Department of Medicine at Laval University and CERVO Brain Research Centre
  • Najah Abi-Gerges, Ph.D.- Vice President, Research & Development at AnaBios Corporation
  • Oleg Yerstein, Ph.D.- Postdoctoral Fellow in the Department of Neurology, David Geffen School of Medicine at University of California; Los Angeles
  • Owen McManus, Ph.D.- Chief Technology Officer at Q-State Biosciences
  • Paul C.H. Li, Ph.D.- Professor in the Department of Chemistry at Simon Fraser University
  • Paul Schnetkamp, Ph.D.- Professor and Associate Dean of Research at the University of Calgary
  • Samir Hanash, Ph.D.- Director, Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center
  • Stefan Feske, M.D., Ph.D.- Jeffrey Bergstein Professor of Medicine and Director of the Ion Channel & Immunity Program at New York University School of Medicine
  • Terry Snutch, Ph.D.- Professor and the Canada Research Chair in Biotechnology and Genomics- Neurobiology at University of British Columbia
  • Tzyh-Chang Hwang, M.D., Ph.D.- Professor in the Department of Medical Pharmacology and Physiology at University of Missouri
  • Vincenzo Macri, Ph.D.- Senior Scientist at STEMCELL Technologies
  • Wayne Giles, Ph.D.- Professor in the Faculty of Kinesiology at University of Calgary
  • William Jia, Ph.D.- CSO and Co-founder of Virogin Biotech, Associate Professor in the Faculty of Medicine at the University of British Columbia
  • Yan Xu, Ph.D.- Peter Winter Professor of Anesthesiology & Perioperative Medicine at University of Pittsburgh
  • Yuji Imaizumi, Ph.D.- Professor in the Department of Molecular and Cellular Pharmacology at Nagoya City University
  • Zhiyuan Li, Ph.D.- Principal Investigator at Guangzhou Institutes of Biomedicine and Health
  • Zhuyin Wang, Ph.D.- Professor at Lanzhou University

Watch our short video of the last Vancouver-based PMICR event

Corporate Sponsors

Media Sponsors

default
Loading posts...
link
#6E787E
on
fadeInUp
loading
#6E787E
off
Back